Lv1
10 积分 2021-09-23 加入
Anti-tumor efficacy of a potent and selective non-covalent KRASG12D inhibitor
2天前
已完结
Safety, Efficacy, and Pharmacokinetics of SHR-A1811, a Human Epidermal Growth Factor Receptor 2–Directed Antibody-Drug Conjugate, in Human Epidermal Growth Factor Receptor 2–Expressing or Mutated Advanced Solid Tumors: A Global Phase I Trial
5天前
已完结
Trastuzumab rezetecan, a HER2-directed antibody–drug conjugate, in patients with advanced HER2-mutant non-small-cell lung cancer (HORIZON-Lung): phase 2 results from a multicentre, single-arm study
5天前
已完结
An FDA oncology analysis of antibody-drug conjugates
6天前
已完结
Bortezomib plus rituximab alone in patients with relapsed, rituximab-naive or rituximab-sensitive, follicular lymphoma: a randomised phase 3 Trial
1个月前
已完结
Bortezomib plus rituximab alone in patients with relapsed, rituximab-naive or rituximab-sensitive, follicular lymphoma: a randomised phase 3 Trial
1个月前
已完结
Follow-up to the pre-validation of a harmonised protocol for assessment of CYP induction responses in freshly isolated and cryopreserved human hepatocytes with respect to culture format, treatment, positive reference inducers and incubation conditions
1个月前
已完结
HepaRG Cells as Human-Relevant In Vitro Model to Study the Effects of Inflammatory Stimuli on Cytochrome P450 Isoenzymes
1个月前
已完结
Understanding Disease–Drug Interactions in Cancer Patients: Implications for Dosing Within the Therapeutic Window
1个月前
已完结
Population Pharmacokinetic Studies of Digoxin in Adult Patients: A Systematic Review
1个月前
已完结
皖公网安备34019202002308
